LivingGLP1
Study S001794

Phase 1 Study of Medtronic Closed Loop Device With ePID Algorithm and Enlite Sensors on Adjuvant Therapy With Insulin and Liraglutide to Minimize Post-prandial Hyperglycemia

Registration

Registration
NCT01755416
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE2
Masking
NONE
Status
COMPLETED
Enrollment
18
Start
2013-01
Primary completion
2015-01
Lead sponsor
Albert Einstein College of Medicine
Conditions
Type 1 Diabetes
Interventions
DRUG:Closed loop with sensor and Insulin; DRUG:Closed loop with sensor, Insulin and Liraglutide
Results posted
TRUE

Registered primary outcomes

  • Blood Glucose Measures in Subjects on Closed Loop With Insulin and Liraglutide, Compared to the Closed Loop With Insulin Alone [0-1500 min]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.